{"schema_version":"secwatch.filing_event.v1","accession":"0001520138-24-000404","form_type":"8-K","ticker":"BIVI","cik":"0001580149","company_name":"BIOVIE INC.","filed_at":"2024-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.863792+00:00","generated_at":"2026-05-30T09:14:23.966834+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BioVie closes registered direct offering raising $3.24M gross proceeds at $2.83/share","bullets":["Closed registered direct offering of 1,146,000 shares at $2.83/share, gross proceeds ~$3.24M.","Net proceeds after fees of ~$419K are approx. $2.82M; funds for working capital and corporate purposes.","ThinkEquity acted as sole placement agent; offering made under shelf registration S-3.","BioVie is a clinical-stage company developing therapies for liver disease and neurological disorders."],"urls":{"canonical":"https://secwatch.observer/filing/0001520138-24-000404","json":"https://secwatch.observer/filing/0001520138-24-000404.json","markdown":"https://secwatch.observer/filing/0001520138-24-000404.md","text":"https://secwatch.observer/filing/0001520138-24-000404.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1580149/000152013824000404/0001520138-24-000404-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1580149/000152013824000404/bivi-20241029_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T09:14:23.966834+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}